| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.11B | +10.2% | +44.1% |
| Cost of Revenue | $1.67B | +1.0% | +18.9% |
| R&D Expense | $194.0M | +3.7% | +7.8% |
| SG&A Expense | $143.0M | +0.0% | +2.9% |
| Operating Income | $998.0M | +18.4% | +131.6% |
| Pre-tax Income | $864.0M | +22.2% | +143.4% |
| Income Tax | $116.0M | +1.8% | +673.3% |
| Net Income | $748.0M | +26.1% | +120.0% |
| EPS (Basic) | $3.38 | +22.9% | +111.2% |
| EPS (Diluted) | $3.27 | +25.8% | +108.3% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.15B | +9.6% | +40.8% |
| Accounts Receivable | $1.20B | -3.9% | +92.4% |
| Inventory | $1.53B | +2.1% | +3.9% |
| Current Assets | $4.30B | +2.1% | +31.0% |
| Total Assets | $8.89B | +2.1% | +17.6% |
| Current Liabilities | $3.24B | -13.8% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.37B | — | — |
| Capital Expenditures | $382.0M | — | — |
| Investing Cash Flow | -$369.0M | — | — |
| Financing Cash Flow | -$1.75B | — | — |
| Free Cash Flow | $1.99B | — | — |
| +34.4% |
| Long-term Debt | $3.46B | -1.0% | -32.7% |
| Total Liabilities | $7.80B | -5.5% | -7.1% |
| Stockholders' Equity | $1.09B | +138.6% | +232.1% |